164 related articles for article (PubMed ID: 37334312)
1. SFI, a sex hormone binding globulin based nomogram for predicting non-alcoholic fatty liver disease in the Chinese population.
Hua X; Zhang H; Yang W; Liu G; Zhang S; Wang Y
Front Endocrinol (Lausanne); 2023; 14():1176019. PubMed ID: 37334312
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease.
Cen C; Wang W; Yu S; Tang X; Liu J; Liu Y; Zhou L; Yu J; Zheng S
Hepatol Int; 2020 Sep; 14(5):808-816. PubMed ID: 32572817
[TBL] [Abstract][Full Text] [Related]
3. A nomogram for discrimination of non-alcoholic fatty liver disease in patients with chronic hepatitis B.
Chen Y; Cao D; Li C; Zhang P; Wang X; Li N; Han Q; Liu Z
Eur J Gastroenterol Hepatol; 2021 Jan; 33(1):69-75. PubMed ID: 32118853
[TBL] [Abstract][Full Text] [Related]
4. A clinical and laboratory-based nomogram for predicting nonalcoholic fatty liver disease in non-diabetic adults: a cross-sectional study.
Qian Y; Sun B; Zhang Y; Zhang M; Jiao X; Lai L; Yang W
Ann Palliat Med; 2022 Jul; 11(7):2349-2359. PubMed ID: 35542976
[TBL] [Abstract][Full Text] [Related]
5. A nomogram incorporated lifestyle indicators for predicting nonalcoholic fatty liver disease.
Peng K; Wang S; Gao L; You H
Medicine (Baltimore); 2021 Jul; 100(26):e26415. PubMed ID: 34190160
[TBL] [Abstract][Full Text] [Related]
6. A Prediction Model Based on Noninvasive Indicators to Predict the 8-Year Incidence of Type 2 Diabetes in Patients with Nonalcoholic Fatty Liver Disease: A Population-Based Retrospective Cohort Study.
Cai X; Zhu Q; Cao Y; Liu S; Wang M; Wu T; Hong J; Ahmat A; Aierken X; Li N
Biomed Res Int; 2021; 2021():5527460. PubMed ID: 34095297
[TBL] [Abstract][Full Text] [Related]
7. Nomogram for predicting the risk of nonalcoholic fatty liver disease in older adults in Qingdao, China: A cross-sectional study.
Wang Z; Cui J; Li X; Gao R; Feng E; Luo G; Guo B; Wu H; Sun Y; Sun J
Asia Pac J Clin Nutr; 2024 Mar; 33(1):83-93. PubMed ID: 38494690
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a nomogram for predicting metabolic-associated fatty liver disease in the Chinese physical examination population.
Zhou B; Gong N; Huang X; Zhu J; Qin C; He Q
Lipids Health Dis; 2023 Jun; 22(1):85. PubMed ID: 37386566
[TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic fatty liver disease risk prediction model and health management strategies for older Chinese adults: a cross-sectional study.
Pan H; Liu B; Luo X; Shen X; Sun J; Zhang A
Lipids Health Dis; 2023 Nov; 22(1):205. PubMed ID: 38007441
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of an online dynamic nomogram based on the atherogenic index of plasma to screen nonalcoholic fatty liver disease.
Peng H; Zhang J; Huang X; Xu M; Huang J; Wu Y; Peng XE
Lipids Health Dis; 2023 Mar; 22(1):44. PubMed ID: 36991386
[TBL] [Abstract][Full Text] [Related]
11. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
[TBL] [Abstract][Full Text] [Related]
12. Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population.
Lind L; Johansson L; Ahlström H; Eriksson JW; Larsson A; Risérus U; Kullberg J; Oscarsson J
World J Hepatol; 2020 Apr; 12(4):149-159. PubMed ID: 32685107
[TBL] [Abstract][Full Text] [Related]
13. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic significance of clinical and laboratory indices in predicting non-alcoholic fatty liver disease during screening studies].
Nosov AE; Zenina MT; Gorbushina OY; Baidina AS; Vlasova EM; Alekseev VB
Ter Arkh; 2021 Aug; 93(8):883-889. PubMed ID: 36286882
[TBL] [Abstract][Full Text] [Related]
15. A nomogram for estimating the probability of nonalcoholic fatty liver disease in a Chinese population: A retrospective cohort study.
Xie W; Chen S
Medicine (Baltimore); 2020 Nov; 99(48):e23049. PubMed ID: 33235066
[TBL] [Abstract][Full Text] [Related]
16. [Association between serum sex hormone-binding globulin and non-alcoholic steatohepatitis].
Zhao XY; Gu TW; Fang D; Sun HX; Bi Y
Zhonghua Nei Ke Za Zhi; 2022 Nov; 61(11):1239-1246. PubMed ID: 36323566
[No Abstract] [Full Text] [Related]
17. Development and validation of a novel non-invasive test for diagnosing fibrotic non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease.
Gao F; Huang JF; Zheng KI; Pan XY; Ma HL; Liu WY; Byrne CD; Targher G; Li YY; Chen YP; Chan WK; Zheng MH
J Gastroenterol Hepatol; 2020 Oct; 35(10):1804-1812. PubMed ID: 32246876
[TBL] [Abstract][Full Text] [Related]
18. Validation of fatty liver index and hepatic steatosis index for screening of non-alcoholic fatty liver disease in adults with obstructive sleep apnea hypopnea syndrome.
Chen LD; Huang JF; Chen QS; Lin GF; Zeng HX; Lin XF; Lin XJ; Lin L; Lin QC
Chin Med J (Engl); 2019 Nov; 132(22):2670-2676. PubMed ID: 31765354
[TBL] [Abstract][Full Text] [Related]
19. Individualized risk prediction of significant fibrosis in non-alcoholic fatty liver disease using a novel nomogram.
Zhou YJ; Ye FZ; Li YY; Pan XY; Chen YX; Wu XX; Xiong JJ; Liu WY; Xu SH; Chen YP; Zheng MH
United European Gastroenterol J; 2019 Oct; 7(8):1124-1134. PubMed ID: 31662869
[TBL] [Abstract][Full Text] [Related]
20. High sex hormone-binding globulin concentration is a risk factor for high fibrosis-4 index in middle-aged Japanese men.
Fujihara Y; Hamanoue N; Yano H; Tanabe M; Akehi Y; Nomiyama T; Yanase T
Endocr J; 2019 Jul; 66(7):637-645. PubMed ID: 31068503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
